Duplication of the pituitary stalk in a patient with a heterozygous deletion of chromosome 14 harboring the thyroid transcription factor-1 gene.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 20685887)

Published in J Clin Endocrinol Metab on August 01, 2010

Authors

S Accornero1, C Danesino, S Bastianello, I D'Errico, A Guala, L Chiovato

Author Affiliations

1: Unit of Internal Medicine and Endocrinology, Fondazione Salvatore Maugeri Instituto di Ricovero e Cura a Carattere Scientifico, University of Pavia, Via Maugeri 10, 27100 Pavia, Italy.

Articles by these authors

Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet (1983) 3.85

Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke (1999) 2.97

Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum Genet (1983) 2.93

Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology (1997) 2.77

PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet (1998) 2.62

Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer (2003) 2.39

Short rib-dysplasia group (with/without polydactyly): report of a patient suggesting the existence of a continuous spectrum. Am J Med Genet (1995) 2.15

Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab (1997) 2.11

Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet (2002) 2.11

Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol (1998) 2.09

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler (2009) 1.98

Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke (1999) 1.80

Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology (1996) 1.74

Headache attributed to infection: observations on the IHS classification (ICHD-II). Cephalalgia (2006) 1.69

Bladder carcinoma in Costello syndrome: report on a patient born to consanguineous parents and review. Am J Med Genet (1999) 1.67

Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Neurology (1999) 1.65

Mutations in the gene encoding thyroid transcription factor-1 (TTF-1) are not a frequent cause of congenital hypothyroidism (CH) with thyroid dysgenesis. Thyroid (1997) 1.56

Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke (1999) 1.55

In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest (2003) 1.54

The same molecular mechanism at the maternal meiosis I produces mono- and dicentric 8p duplications. Am J Hum Genet (1996) 1.53

Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann Intern Med (1998) 1.53

A novel mutation and novel features in Nijmegen breakage syndrome. J Med Genet (2001) 1.50

Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol (1992) 1.50

Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet (2001) 1.46

Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid (2001) 1.45

What insights have new imaging techniques given into aggressive forms of MS--different forms of MS or different from MS? Mult Scler (2008) 1.45

Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer (1996) 1.45

Familial metoclopramide-induced dystonic reactions. Mov Disord (1992) 1.44

Thyroid and lipid metabolism. Int J Obes Relat Metab Disord (2000) 1.42

Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology (2001) 1.42

Insulin autoantibodies as markers of potential diabetes mellitus. Lancet (1989) 1.40

Failure to detect thyroid growth-promoting activity in immunoglobulin G of patients with endemic goiter. J Clin Endocrinol Metab (1994) 1.40

Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab (1983) 1.40

Hand weakness from a precentral gyrus infarct with intermittent hypotension. Neurology (2001) 1.39

Study of serum 3,5,3'-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness. Eur J Endocrinol (1996) 1.38

Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician. J Neurol Sci (2000) 1.38

ICHD-II diagnostic criteria for Tolosa-Hunt syndrome in idiopathic inflammatory syndromes of the orbit and/or the cavernous sinus. Cephalalgia (2008) 1.34

Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation (2000) 1.32

Kenny-Caffey syndrome in two sibs born to consanguineous parents: evidence for an autosomal recessive variant. Am J Med Genet (1992) 1.26

Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol (2001) 1.25

Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature (1983) 1.25

Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol (1995) 1.24

Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dsfunction in apparently healthy subjects. J Endocrinol Invest (2001) 1.23

Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet (1998) 1.20

Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis. J Med Genet (2006) 1.20

Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery (1996) 1.17

Changing prognosis of primary intracerebral hemorrhage: results of a clinical and computed tomographic follow-up study of 104 patients. Stroke (1988) 1.17

Diagnosis of glycogenosis type II. Neurology (2008) 1.16

Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke (1989) 1.14

Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology (1998) 1.14

Letter: Genetic heterogeneity in fucosidosis. Lancet (1973) 1.13

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol (1997) 1.12

The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome. Leukemia (2009) 1.12

Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet (1996) 1.10

Intracranial actinomycosis in juvenile patients. Case report and review of the literature. Childs Nerv Syst (1998) 1.07

Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood (2001) 1.07

Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J Med Genet (2001) 1.07

Familial clustering of Langerhans cell histiocytosis. Br J Haematol (1999) 1.06

Twenty-five novel mutations including duplications in the ATP7A gene. Clin Genet (2011) 1.06

Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica (2001) 1.05

Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease. Dig Liver Dis (2005) 1.04

Evaluation of the rat thyroid cell strain FRTL-5 as an in-vitro bioassay system for thyrotrophin. J Endocrinol (1984) 1.03

Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol (1997) 1.03

Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid (1997) 1.03

Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Mult Scler (2011) 1.02

Familial partial monosomy 7 and myelodysplasia: different parental origin of the monosomy 7 suggests action of a mutator gene. Cancer Genet Cytogenet (2001) 1.02

Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non thyroid illnesses and in lymphoreticular system disorders. J Endocrinol Invest (1983) 1.02

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain (1998) 1.01

Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart (1998) 1.00

Ring chromosome and latent centromeres. Cytogenet Cell Genet (1980) 0.99

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.99

Ring chromosome 13 with loss of the region D13S317-D13S285: phenotypic overlap with XK syndrome. Am J Med Genet (1997) 0.99

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.99

Transcranial Doppler in acute hemispheric brain infarction. Neurology (1991) 0.98

The Coffin-Siris syndrome in two siblings. Pediatr Radiol (1986) 0.97

Types, stability, and phenotypic consequences of chromosome rearrangements leading to interstitial telomeric sequences. J Med Genet (1993) 0.95

Constitutional trisomy 8 as first mutation in multistep carcinogenesis: clinical, cytogenetic, and molecular data on three cases. Genes Chromosomes Cancer (1996) 0.95

Management and treatment of glycogenosis type II. Neurology (2008) 0.95

Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient. Eur J Clin Microbiol Infect Dis (1991) 0.95

Diagnostic application of first trimester trophoblast sampling in 100 pregnancies. Hum Genet (1984) 0.94

Asymmetric Marfan syndrome. Am J Med Genet (1988) 0.94

The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS. J Neurol (2003) 0.93

Interstitial deletion of chromosome 1 (q23-q25). Report of a case. Clin Genet (1984) 0.93

Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination. J Neurol (1995) 0.93

Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. Acta Neurol Scand (1996) 0.92

Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials. Neurology (1997) 0.92

Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter? Eur J Echocardiogr (2008) 0.92

Correlation of angiographic and sequential CT findings in patients with evolving cerebral infarction. AJNR Am J Neuroradiol (1990) 0.92

Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release. J Biol Chem (2000) 0.92

Acute ischemic strokes improving during the first 48 hours of onset: predictability, outcome, and possible mechanisms. A comparison with early deteriorating strokes. Stroke (1997) 0.92

Solubilization of human thyroid microsomal antigen. J Clin Endocrinol Metab (1979) 0.92

Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin. J Endocrinol Invest (1993) 0.92

Mild iodine deficiency during fetal/neonatal life and neuropsychological impairment in Tuscany. J Endocrinol Invest (1995) 0.91

Thyroid resistance to TSH complicated by autoimmune thyroiditis. J Clin Endocrinol Metab (2001) 0.91

Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases. Clin Endocrinol (Oxf) (1992) 0.91

Mutation analysis of the RPGR gene reveals novel mutations in south European patients with X-linked retinitis pigmentosa. Eur J Hum Genet (1999) 0.91

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. J Neurol Sci (2000) 0.91

Pure motor hemiparesis and sensorimotor stroke. Accuracy of very early clinical diagnosis of lacunar strokes. Stroke (1994) 0.91

Functional disomy of Xp22-pter in three males carrying a portion of Xp translocated to Yq. Hum Genet (1993) 0.91